Richard Doskey, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9605 Jefferson Hwy, River Ridge, LA 70123 Phone: 504-738-1604 Fax: 504-738-7860 |
Meghan Jones, MD, MPH Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8908 Ormond Pl, River Ridge, LA 70123 Phone: 504-610-1171 |
Dr. Courtney Jacobs, M.D. Pediatrics - Pediatric Emergency Medicine Medicare: Medicare Enrolled Practice Location: 864 S Clearview Pkwy, Apt 136, River Ridge, LA 70123 Phone: 781-696-2530 |
Denise Goodfellow Kerut, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9605 Jefferson Highway, River Ridge, LA 70123 Phone: 504-738-1604 Fax: 504-738-7860 |
Anas Youssef Khouri, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9605 Jefferson Hwy, River Ridge, LA 70123 Phone: 504-738-1604 Fax: 504-738-7860 |
Mary Hulin, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9605 Jefferson Hwy Ste E, River Ridge, LA 70123 Phone: 504-738-1604 Fax: 504-738-7860 |
Janine Lissard, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9605 Jefferson Hwy, River Ridge, LA 70123 Phone: 504-738-1604 Fax: 504-738-7860 |
News Archive
The widespread adoption of the use of drug-releasing coronary artery stents into routine practice is associated with a decrease in the need for repeat procedures to unblock coronary arteries and also do not appear to increase the risk of death, compared to bare-metal stents, according to a study in the June 25 issue of JAMA, the Journal of the American Medical Association
Tumors need a healthy supply of blood to grow and spread. Researchers at the Stanford University School of Medicine have identified a molecule that regulates blood vessel growth that is often found at less-than-normal levels in human tumors. Blocking the expression of the molecule, called PHD2, allows human cancer cells to grow more quickly when implanted into mice and increases the number of blood vessels feeding the tumor.
Although demand for COVID-19 vaccines currently seems high, vaccine hesitancy could pose a major threat to public health efforts to end the pandemic, according to an editorial published today in the journal Science.
A new combination of bortezomib (Velcade) and two other drugs is showing a very high response rate in patients newly diagnosed with multiple myeloma, a team headed by Dana-Farber Cancer Institute investigators reported at the annual meeting of the American Society of Hematology.
› Verified 2 days ago